Please join us on Monday, November 26, 2018, in Washington, DC, for a momentous occasion reflecting on the 100th anniversary of the influenza pandemic of 1918. A panel discussion entitled “A Century After the 1918 Influenza Pandemic—Why Are We Still Concerned Today?” cohosted by the National Academy of Medicine, with the Forum on Microbial Threats, will be held from
On December 3, 2018, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM), with participation from the FDA’s Center for Biologics Evaluation and Research (CBER), will hold a public webinar about genome editing in animals. Genome editing is an innovative and rapidly evolving technology that offers many promising benefits to both human and
Join Doctors Without Borders for a live webcast panel discussion on January 29 from 12:30 PM – 2:00 PM EST on efforts to contain the current Ebola epidemic in Democratic Republic of Congo (DRC). MSF teams are responding to the second largest Ebola outbreak ever recorded, trying to halt the spread of this highly infectious,
The National Toxicology Program will host a public webinar on 4 Feb 2019 to discuss the draft findings of a systematic review to evaluate the evidence for long-term neurological effects in humans and animals following acute exposure to sarin. Sarin is a highly toxic organophosphorus nerve agent that was developed for chemical warfare during World War II
The Blue Ribbon Study Panel on Biodefense will host an in-depth discussion on the role of the U.S. Defense Department in biodefense on February 5th, 2019 in Washington, DC. Participants will share their experiences regarding the current threat environment, research and development programs, and the Department's biodefense policies. RSVP by January 30, 2019. Attendance is
The London School of Hygiene & Tropical Medicine Antimicrobial Resistance Center, together with the MARCH and Malaria Centres will jointly host the Mass Drug Administration and Antimicrobial Resistance Symposium on 20 February 2019 in London, UK and by live stream. Mass Drug Administration is an intervention proposed to reduce morbidity and mortality of entire populations. This symposium
